T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition - Archive ouverte HAL Access content directly
Journal Articles Cancer Immunology Research Year : 2015

T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition

Abstract

Tumor immunotherapy has had demonstrable efficacy in patients with cancer. The most promising results have been with T-cell-based therapies. These include adoptive cell transfer of tumor-infiltrating lymphocytes, genetically engineered T cells, and immune checkpoint inhibitor antibodies. In this review, we describe the different T-cell-based strategies currently in clinical trials and put their applications, present and future, into perspective. Cancer Immunol Res; 3(10); 1115-22. ©2015 AACR
Not file

Dates and versions

hal-01216199 , version 1 (15-10-2015)

Identifiers

Cite

Roch Houot, Liora Michal Schultz, Aurelien Marabelle, Holbrook Kohrt. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition. Cancer Immunology Research, 2015, 3 (10), pp.1115--1122. ⟨10.1158/2326-6066.CIR-15-0190⟩. ⟨hal-01216199⟩
72 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More